The consequence demonstrated that high ZSCAN20 expression corresponded to undesirable prognosis (OS, RFS, and DSS) in HCC patients (p < 0.05) (Figure 3A–3C). The gene discussed is ZSCAN20; the disease is hepatocellular carcinoma.